Skip to main content
Dr Layloma Rashid avatar
Reviewed profileID verifiedEEAT
StocksAI

TECHi author

Dr Layloma Rashid

News Writer

@layloma

Stories

413

419K total views

Author score

64

Profile reviewed

First story

July 23, 2025

Member since June 28, 2025

Connect

Dr Layloma Rashid brings a clinical lens to healthcare investing. She translates FDA filings, Phase 3 readouts, and PDUFA calendar dates into analysis readers can act on — covering large-cap pharma, medical-device makers, and the oncology and GLP-1 pipelines reshaping the sector. Her coverage weighs ClinicalTrials.gov data against management guidance and flags where sell-side models diverge from what trial design actually supports. She writes about drug development with the skepticism Phase 2 success rates deserve.

Sign in for alertsGet email alerts when Dr publishes new reports.

Track record

Quality & trust dashboard

Scores roll up from Dr Layloma Rashid's published work, editorial quality signals, and identity verification. All values 0-100.

Published

415

Articles on TECHi

Total views

418.9K

Across all work

Author ScoreBuilding
64/100

TECHi's composite score — blends output volume, community ratings, fact-check accuracy, identity verification, and profile completeness.

TrustNot measured

Reader trust score is shown after enough article-level votes exist. Until then, TECHi does not display a synthetic trust score.

Fact-checkNot measured

Fact-check score is shown only when reviewed article-level evidence exists. Empty means unmeasured, not failed.

EngagementNot measured

Engagement score appears once analytics-backed interaction data has been attached to this author.

OutputExcellent
100/100

Publishing cadence and volume normalized over time. Rewards consistent output without overweighting prolific drive-bys.

QualityPending review

Quality score is displayed after measurable trust or fact-check data exists. Verification alone does not create a quality score.

IdentityExcellent
100/100

Identity verified via manual_review. Confirmed by TECHi.

Profile completenessBuilding
57/100

Filled profile sections: headline, bio, avatar, social links, expertise, location. Higher = better reader context.

Field confirmed

0

Facts that community fact-checkers reviewed and confirmed as accurate. A dash means this signal is not tracked yet.

⚠︎

Accepted corrections

0

Approved corrections tied to this author in TECHi's public corrections log. Zero means no approved public correction is on record.

Revisions shipped

0

Post-publish updates the author submitted and an editor approved. Signals active stewardship of evergreen content.

TECHi Reviewed Author ProfileID VerifiedE-E-A-T profile complete

Author profile

Editorial output from Dr Layloma Rashid

Articles

413

Views

418.9K

Score

64

Latest

May 28, 2026

Since Jul 23, 2025

Beat map

Markets & Equities10
AI & Intelligence4
Tech Breakthroughs3
Crypto & DeFi1

Publishing cadence

Output over 12 months

18 articles across 3 active months.

14
1
3
JulAugSepOctNovDecJanFebMarAprMayJun

Lead story

Most recent publish - open the full analysis or scroll for the full archive.

Archive

Latest analysis

Stocks, crypto, AI, and policy - reporting and commentary on TECHi (showing 18 of 304).

Legacy archive

Pre-pivot work

7 articles from Dr Layloma Rashid's earlier era on TECHi (pre-2026 financial-coverage pivot). URLs still resolve and Google can crawl them, but they're not on the current beat.

Topic mix

Coverage breakdown

Where Dr's recent stories cluster — jump into a desk.